BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 877349)

  • 1. [Guidelines and results in the treatment of thyroid cancer].
    Ortíz Berrocal J; Sopena Monforte R; Carril Carril JM; Ramos Sánz J; Martínez R; Chamorro Romero JL
    Rev Clin Esp; 1977 Jun; 145(5):361-8. PubMed ID: 877349
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of thyroid carcinoma. Results of 19 years' use of I-131].
    Gordon F; Juan-Marcos H; Muñoz R
    Gac Med Mex; 1983 Sep; 119(9):356-60. PubMed ID: 6642131
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
    Baranauskas ZL; Mamontov VV; Valutskas KK
    Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioactive iodine in the treatment of thyroid carcinoma].
    Pendić S; Tasić S
    Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bone marrow depression due to 131I treatment of thyroid cancer].
    Keldsen N; Mortensen BT; Hansen HS
    Ugeskr Laeger; 1988 Nov; 150(46):2817-9. PubMed ID: 3206692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant goiter. Retrospective analysis of the patient material and treatment results at the Division of Nuclear Medicine of the 2nd Medical Department of Vienna University from 1973 to 1982].
    Weissel M; Bergmann H; Steidler B; Keminger K; Krisch K; Niederle B; Roka R; Schmalzer E; Willvonseder R; Höfer R
    Acta Med Austriaca; 1983; 10(2-3):83-91. PubMed ID: 6880577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the plan of therapy on prognosis in thyroid cancer].
    Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid cancer guidelines--what's new?
    Gerrard G; Gill V
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):264-6. PubMed ID: 18343311
    [No Abstract]   [Full Text] [Related]  

  • 10. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.
    Beierwaltes WH; Rabbani R; Dmuchowski C; Lloyd RV; Eyre P; Mallette S
    J Nucl Med; 1984 Dec; 25(12):1287-93. PubMed ID: 6502251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-surgical treatment of thyroid neoplasms].
    Klepp O
    Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1287-90. PubMed ID: 1179338
    [No Abstract]   [Full Text] [Related]  

  • 12. Iodine-131 therapy of thyroid cancer: extensive contamination of the hospital room in a patient with tracheostomy.
    Kappes RS; Sarkar SD; Har-El G; Strashun AM; Dunn EK; Schussler GC
    J Nucl Med; 1994 Dec; 35(12):2053-4. PubMed ID: 7989991
    [No Abstract]   [Full Text] [Related]  

  • 13. Functioning thyroid carcinomas--some historical aspects.
    Larsson LG
    Acta Oncol; 2006; 45(8):1062-6. PubMed ID: 17118840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results obtained in the treatment of hyperfunctional thyroid adenomas with I-131].
    Holan T; Micluţia M; Derevenco V
    Stud Cercet Endocrinol; 1972; 23(4):271-9. PubMed ID: 4681160
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 16. An analysis of the results of initial treatment for patients with malignant tumours of the thyroid seen at the Royal Marsden Hospital, 1945-1963.
    Staunton MD; Martin M
    Monogr Neoplast Dis Var Sites; 1970; 6():276-90. PubMed ID: 4950335
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of papillary carcinoma of the thyroid occurring after irradiation.
    Crile G
    Surg Gynecol Obstet; 1980 Jun; 150(6):850-2. PubMed ID: 7376046
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
    Bricout P; Kibler RS
    J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
    [No Abstract]   [Full Text] [Related]  

  • 19. 131I effective half-life (Teff) for patients with thyroid cancer.
    Willegaignon J; Malvestiti LF; Guimarães MI; Sapienza MT; Endo IS; Neto GC; Marone M; Sordi GM
    Health Phys; 2006 Aug; 91(2):119-22. PubMed ID: 16832192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgery and follow-up 131I therapy in patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compliance with the 1987 consensus guidelines: additional data].
    Kuijpens JL; Verheij CD; Haak HR; Ribot JG; Hoekstra OS; Coebergh JW
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1835-6. PubMed ID: 15495514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.